Institutional investors purchased a net $3.1 million shares of ICLR during the quarter ended June 2015 and now own 96.10% of the total shares outstanding. This majority interest is a greater percentage than is typical for companies in the Pharmaceuticals: Other industry and highlights that the smart money sees this stock as an important holding.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
WCM INVESTMENT MANAGEMENT Bought 3.7 Million shares of ICON PLC